Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.

Autor: Ghezelayagh, Talayeh S.1 tghezel@uw.edu, Wu, Emily S.1,2, Barber, Emma L.3, Dao, Minh D.1, Zsiros, Emese4,5, Urban, Renata R.1, Gray, Heidi J.1, Goff, Barbara A.1, Shah, Chirag A.6, Neubauer, Nikki L.3,7, Dai, James Y.8, Tanyi, Janos L.4, Liao, John B.1 johnliao@uw.edu
Zdroj: European Journal of Gynaecological Oncology. Feb2023, Vol. 44 Issue 1, p17-25. 9p.
Databáze: Academic Search Ultimate